Brigit Biofarmaka Teknologi Tbk. vs Damai Sejahtera Abadi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Damai Sejahtera Abadi Tbk. trades at Rp145 (market cap 399.96B, 3.1M 24h volume). The key difference: Damai Sejahtera Abadi Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Damai Sejahtera Abadi Tbk. is more actively traded (3.1M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | UFOE | |
|---|---|---|
Market Cap | 172.82B | 399.96B |
Volume | 592.2K | 3.1M |
Lot | 5.92K | 31K |
Turnover | 147.05M | 430.17M |
Average Price | 248.31 | 138.78 |
Value | 147.05M | 430.17M |
Indicative Equilibrium Price | 254 | 145 |
Indicative Equilibrium Volume | 10 | 1.5K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Damai Sejahtera Abadi Tbk (the Company) was established in Surabaya based on Notarial Deed No. 46 of Setiawati Sabarudin, S.H., Notary in Surabaya, dated January 29, 2004. The Company’s immediate parent company is PT Damai Sejahtera Lestari, which is ultimately owned by Mr. Pudji Harianto and Mr. Poedji Harixon.
Read more on UFOE →